Corinne Le Goff is the Chief Commercial Officer at Viatris Inc., a global healthcare company formed through the merger of Mylan and Upjohn in 2020. In this pivotal role, she oversees the company's commercial strategy, driving growth across diverse markets and therapeutic areas, including generics, biosimilars, and branded medicines. Le Goff's leadership focuses on expanding access to affordable healthcare solutions worldwide, leveraging her expertise in commercial operations to navigate complex regulatory environments and foster partnerships that enhance patient outcomes. Her strategic vision has been instrumental in positioning Viatris as a leader in addressing unmet medical needs, particularly in emerging markets and chronic disease management. With over two decades of experience in the pharmaceutical and biotechnology sectors, Le Goff brings a wealth of knowledge from previous high-profile positions. Before joining Viatris in 2023, she served as Chief Commercial Officer at Moderna, where she played a key role in the global commercialization of the company's COVID-19 vaccine, contributing to one of the fastest vaccine rollouts in history. Prior to that, she held senior roles at Amgen, Roche, and Sanofi, where she led international teams in marketing, sales, and business development, achieving significant revenue growth and successful product launches in oncology, immunology, and rare diseases. Her achievements include negotiating multi-billion-dollar deals and implementing innovative go-to-market strategies that have expanded market share and improved healthcare accessibility. Beyond her corporate accomplishments, Le Goff is recognized for her commitment to diversity and inclusion in the industry, advocating for women in leadership roles and mentoring emerging talent. She holds a Master's degree in Pharmacy from the University of Paris and an MBA from INSEAD, blending scientific acumen with business savvy. At Viatris, her forward-thinking approach continues to drive sustainable growth, emphasizing innovation, operational efficiency, and a patient-centric ethos that aligns with the company's mission to empower people worldwide to live healthier lives.